SHIVTAF 25 MG is a high-quality allopathic antiviral formulation offered by Sigma Nexus, a trusted pharmaceutical exporter and supplier based in Jaipur, India. With over 10 years of industry experience, Sigma Nexus is committed to delivering safe, effective, and globally compliant pharmaceutical solutions to both domestic and international markets. Manufactured in WHO-GMP and ISO-certified facilities, SHIVTAF 25 MG adheres to stringent international quality standards, ensuring consistent efficacy, safety, and reliability.
SHIVTAF 25 MG is primarily used in the treatment and management of Human Immunodeficiency Virus (HIV) infection and chronic Hepatitis B virus (HBV) infection. It typically contains Tenofovir Alafenamide (TAF), an advanced prodrug of tenofovir that offers effective antiviral activity at lower doses with improved safety profiles, particularly for kidney and bone health. As a nucleotide reverse transcriptase inhibitor (NRTI), SHIVTAF 25 MG works by blocking the action of reverse transcriptase, an essential enzyme required for viral replication. By inhibiting this process, it helps reduce viral load, slow disease progression, and support immune system function.
One of the key advantages of SHIVTAF 25 MG is its enhanced intracellular delivery, allowing effective viral suppression with reduced systemic exposure compared to older formulations. This makes it a preferred choice in modern antiretroviral therapy (ART) regimens. It is often used in combination with other antiretroviral medicines to achieve long-term viral suppression and improve patient outcomes.
Formulated using high-purity active pharmaceutical ingredients (APIs), SHIVTAF 25 MG ensures optimal bioavailability and consistent therapeutic performance. Sigma Nexus follows strict quality assurance protocols throughout the manufacturing process, including raw material sourcing, formulation, packaging, and final quality testing. Each batch is thoroughly evaluated to meet global pharmaceutical benchmarks, ensuring safety and effectiveness for patients worldwide.
Sigma Nexus has built a strong international presence, exporting pharmaceutical products to markets such as the USA, UK, UAE, Africa, and Southeast Asia. With a robust logistics and supply chain network, the company ensures timely delivery and continuous availability of essential medicines like SHIVTAF 25 MG. The product is securely packaged to maintain its stability, potency, and shelf life during transportation and storage under various environmental conditions.
In addition to supplying finished formulations, Sigma Nexus offers value-added services including third-party manufacturing and private labeling. These services allow global partners to customize packaging, branding, and product specifications according to their specific market requirements. The company also provides complete support for product registration and regulatory compliance, helping clients navigate approval processes across different countries.
SHIVTAF 25 MG should be used strictly under the supervision of a qualified healthcare professional. The dosage and duration of treatment depend on the patient’s medical condition, viral load, and response to therapy. Regular monitoring is essential to ensure effective treatment and patient safety.
With a strong focus on quality, compliance, and customer satisfaction, Sigma Nexus continues to expand as a reliable pharmaceutical exporter from India. By offering advanced antiviral solutions like SHIVTAF 25 MG, the company contributes to improving global access to life-saving treatments and enhancing healthcare outcomes worldwide.